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Two-year chemical carcinogenesis studies
using rodents are the major bioassay for
identifying environmental carcinogens
(1-3). Due largely to the limited number of
animals per test (generally 50-60 animals of
each sex of two species, rats and mice, in
each experimental group), bioassays are con-
ducted at relatively high exposure concen-
trations to optimize the probability of
detecting a carcinogenic response. These
long-term bioassays were originally designed
primarily for qualitative identification of
potential human carcinogens, so that further
studies could be done as necessary to eluci-
date dose-response relationships for quanti-
tative risk assessment. Unfortunately, subse-
quent experiments are often not possible
due to limited resources and the need to test
other chemicals; thus, carcinogenesis bioas-
say data are frequently used for quantitative
risk assessments, despite potential limita-
tions andconfounding factors (4).
Carcinogenesis bioassays have been
criticized for identifying "too many rodent
carcinogens" and are criticized as not pre-
dicting carcinogenic hazards to humans,
largely because ofpurported differences in
exposures and lack ofdiscrimination due to
high-dose effects (5). Long-term bioassays
are designed to expose rodents to chemicals
or environmental mixtures that cause only
minimal toxic effects. The highest dose
selected for these studies has been termed
the "maximum tolerated dose" (MTD),
when, in fact, it actually represents a mini-
mally toxic exposure dose (6-8). Since
nearly half the chemicals tested by the
National Cancer Institute (NCI) (9) and
the National Toxicology Program (NTP)
(10) elicited a positive response in the
rodent bioassays, some researchers have
postulated that carcinogenesis in these
studies results from cell killing and
increased cell division (mitogenesis) (5).
However, no obvious correlation between
toxicity and carcinogenicity exists (11-14).
Mitogenesis is certainly crucial to the car-
cinogenic process (5,15-18), but the con-
clusion that the majority of positive car-
cinogenesis responses results from cell
killing and mitogenesis requires a more
critical evaluation (11,12,17-19).
Most of the chemicals selected for the
NCI/NTP rodent bioassay program were
suspect carcinogens. Thus, not surprisingly,
many of these chemicals (two-thirds) did
induce carcinogenic responses in well-con-
trolled, 2-year rodent carcinogen bioassays.
More criteria are used to predict the car-
cinogenic potential of chemicals since the
inception ofthe bioassay program, as more
information on mechanisms ofcarcinogen-
esis have become available. These criteria
include 1) positive or suggestive evidence
from epidemiological studies or previous
experimental studies in animals, 2) poten-
tial to act as an electrophilic agent or to be
metabolized to an electrophilic species, 3)
potential to be metabolized to active free
radical species, and 4) known biological
activity, such as genotoxicity (20-23).
Other information useful for assessing
potential carcinogenicity includes data on
levels and duration of exposure to the
chemical, potential for bioaccumulation,
mechanism ofcarcinogenic activity, species
differences, and geneticsusceptibility.
Some chemicals were selected for car-
cinogenicity testing based primarily on esti-
mates of human exposures, without prior
suspicion of carcinogenicity. Estimates of
exposure were based on 1) production vol-
ume; 2) use pattern (e.g., is the chemical an
intermediate or end product, is it used in an
open or dosed system, is it used in occupa-
tional settings or bycertain subgroups ofthe
general population); 3) environmental
occurrence (e.g., naturally occurring prod-
ucts in certain foods and environmental pol-
lutants such as pesticides); 4) potential to
enter the food chain; 5) physical properties
(e.g., vapor pressure and partition coeffi-
cients) that are relevant to the route of
human exposure; 6) potential for bioaccu-
mulation; and 7) worker and consumer
exposure databases. This subset ofchemicals
represents a more randomly selected group
of substances to ascertain more accurately
the percentage ofchemicals that are carcino-
genic to rodents, assess whether testing
chemicals at minimally toxic exposure levels
generally results in carcinogenic responses,
and predict the proportion ofchemicals that
maypose a carcinogenic riskto humans.
In this paper we have divided chemicals
tested for carcinogenicity into two cate-
Theselection process forchemicalstested in
therodent ogenicit bioassayhas been
biasedtowardchemicals suspead ofpoten-
tial carcinonicity. Results fiom carcino-
genicityboassays of 400. icals tested
by te NaioN l Cacer lniNational
ToxicologyProgram (NCIINTP) wer ana-
lyzed to determine the dependence ofposi-
tive results on chemical selection criteria:
those suspected of being carcinogenic and
those selected based on large volumes pro-
duced and widespread e Of these
chemicals, 210(52%) ind d carcinogenic-
ity in at least one organ of one sex of one
species of the four sex/species groups typi-
cally used by NCI/NTP. Only 92 ofthe
400 cemis (23%) were positive in two
species andthus byinternational criteria are
considered likelyto pose acrci haz-
ard to humns. A total of267 chemicals
(67%) welected as suspectcinoens,
and 187 (68%) ofthese were inogenic
Suspect chemicals account for 86% of
chemicals with at least one positive result
and account for 90% ofchemials consid-
ered positive in two species. The Inter-
national AgenCy for Research own Cancer
(IARC) is only 5 ofthe 40 c s as
carcinogenic tohumans (gioup 1) and 10 as
probably carcinogenic to humans (group
2A). The majority (80%) ofthe 133 chemi-
cals selected only on production/exposure
considerations were not cognc in ani-
m ew n te e t e m i tol-
erated (or minimally toxic) :dos. Only 9
(6.8%) were positive in two species, and
none is listed in IARC groups 1 or 2A.
Thus, on the basis ofour analyses we pre-
dict that less than 5-10% ofthe 75,000
chmics in commercial use might be rea-
sonabl aiipated to be cinogenic to
humans. (Cry werd chemicl carinogene-
sit, human catcinogens, National Cancer
Institute/National Toxicology Program
bioassay program, predictive animal data.
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gories: those selected on the basis ofbeing
suspect carcinogens and those selected on
the basis of exposure/production volume.
Two-thirds of the suspect carcinogens
exhibited carcinogenic activity, whereas
the majority (nearly 80%) ofthe high-vol-
ume chemicals were not carcinogenic, even
when tested at relatively high exposures.
The scientific and public health signifi-
cance ofthese observations is discussed.
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Bioassay Results of400 Chemicals
As ofJune 1994, NCI/NTP has completed
carcinogenicity bioassays on 400 chemi-
cals, and these have been peer reviewed in
public forums. Of the 400 chemicals test-
ed, 210 (52%) showed a statistically signif-
icant increase in the numbers of animals
with tumors in at least one site or one
organ ofone sex ofone species in the four
typical sex-species groups of one or more
exposure levels (Table 1). Fifty-five of the
210 "positive" chemicals were positive in
only 1 sex-species group, 79 chemicals in
2 groups, 31 chemicals in 3 groups, and 45
chemicals in 4 groups (Table 2).
Our review of the selection criteria for
the 400 chemicals indicated that 267
(67%) were selected with a suspicion of
carcinogenicity, and 133 (33%) were
selected mainly on the basis ofproduction
volumes and occupation/population expo-
sures. Of the 210 positive chemicals, 181
(86%) were suspect carcinogens, and 29
(14%) were selected mainly on exposure
considerations (Table 2). These results
clearly demonstrate a bias in the chemical
selection process toward chemicals that are
suspect carcinogens.
Further analysis of the 181 positive
chemicals that were suspect carcinogens
showed that 42 were positive in only 1 of4
sex-species groups, 70 in 2 groups (14 of
these chemicals were positive in 2 species),
27 in 3 groups, and 42 in all 4 groups
(Table 2). Thus, 83 (14 + 27 + 42) ofthe
267 suspect carcinogens tested were posi-
tive in 2 species and thus meet the interna-
tional criteria to evaluate further for poten-
tial human cancer risk.
Only 29 of the 133 chemicals (22%)
selected mainly on the basis of exposure
considerations were positive in at least 1 of
the 4 sex-species groups, 13 of these 29
chemicals were positive in only 1
sex-species group; 9 chemicals in 2 groups
(2 of these chemicals were positive in 2
species), 4 chemicals in 3 groups, and 3
chemicals in all 4 experimental groups.
Thus, 9 (2 + 4 + 3) of the 133 chemicals
tested (6.8%) were positive in two species
and would be considered for further evalu-
ation as possibly carcinogenic to humans.
Chemicals Likely to Pose
Carcinogenic Hazards to Humans
According to the strength-of-evidence crite-
ria pioneered by the International Agency
for Research and Cancer (IARC), which are
used by the Department of Health and
Human Services (DHHS) in its Annual
Report on Carcinogens (ARC) and by others,
chemicals that induce cancer in two species
should be considered most likely to pose
carcinogenic hazards to humans (24-27)
and need more detailed and extensive evalu-
ation ofthe available data and information.
These empirical and qualitative scientific
criteria have been adopted by research and
regulatory agencies worldwide for evaluating
the available information to determine
whether a chemical is carcinogenic to
humans. Thus, 92 (44%) of the 210 posi-
tive chemicals (or 23% ofthe 400 chemicals
tested) should be further evaluated as poten-
tial human carcinogens. Eighty-three of
these 92 chemicals (90%) were suspect car-
cinogens; only 9 (10%) were selected main-
ly on the basis ofproduction and exposure
considerations. It is noteworthy that less
than halfofthe 210 positive chemicals and
only 23% (92/400) of all chemicals tested
by NCI/NTP would be considered for fur-
ther evaluation as likely to present carcino-
genic hazards to humans using international
criteria (e.g., IARC). Ofcourse, we do not
mean to imply that chemicals with positive
results in only one species or in one sex of
one strain are necessarily not hazardous, for
each chemical must be evaluated individual-
ly using all available toxicologic information
to better determine potential carcinogenic
risks to humans.
Classification ofChemicals by LARC
and DHHS
To date, 75{ (36%) of the 210 positive
chemicals (or 19% of the 400 total chemi-
cals) have been classified by IARC and/or
DHHS. Sixty-three chemicals areconsidered
byIARC as posing cancer risks to humans: 5
of these chemicals are in IARC group 1
("agent is carcinogenic to humans"), 10
chemicals are in group 2A ("agent is proba-
bly carcinogenic to humans"), and 48 chem-
icals are inp-oup 2B ("agent is possibly car-
cinogenic to humans"). Sixty chemicals are
listed by DHHS in the Annual Report on
Carcinogens (ARC) as presenting carcino-
genic hazards to humans: 4 chemicals are
listed as "known to be carcinogenic to
humans" (4 ofthe 5 in IARC) and 56 chem-
icals are listed as "reasonably anticipated to
be a carcinogen to humans." For the majori-
ty of the chemicals there is excellent corre-
spondence for listing by both IARC and in
the ARC. The categories of evidence and
names of the chemicals are provided in
Tables 3 and4.
Sixty-eight of the 75 chemicals (91%)
listed by IARC or in the ARCwere selected
as suspect carcinogens, and 7 (9%) were
selected on the basis of human exposure
considerations. Fifty-seven ofthe 181 posi-
tive chemicals (32%) selected as suspect
carcinogens are listed in one of the IARC
categories: group 1 (5 chemicals), group
2A (10 chemicals), and group 2B (42
chemicals). Fifty-five of the 181 positive
chemicals (30%) are listed in the ARC: 4
chemicals in the "known to be carcino-
genictv humans" and 51 in the "reason-
ablyanticipated to be a carcinogen" classi-
fication. 'Table 3 contains the names ofthe
chemicals in the various IARC and ARC
categories ofevide ce.
Six ofthe 29 chemicals (21%) selected
dn the basisof ex osure considerations are
listed in IARC group 2B; none is listed in
group 1 or group 2A. Five ofthe 29 chem-
icals (17%) are listed in ARCclassification,
"reasonably anticipated to be a carcino-
gen"; none is listed in the "known" classifi-
cation. Table 4 contains the names ofthese
chemicals in the various IARC and ARC
classifications.
Magnitude ofPublic Health
Problem
These results may be used to better predict
the percentage of the 75,000 chemicals in
commercial use that would eventually
prove to be carcinogenic to humans; of
Table 1. Statistics on selection rationale for 400 chemicals/chemical mixtures with published or peer-
reviewed technical reports as ofJanuary 1994
Selection basis
Completed bioassays
Suspicion of carcinogenicity
Production volumes and
occupation/population exposures
Total no. of
chemicals (%)
400
267 (67)
133 (33)
No. of chemicals with
Positive results (%) Negative results (%)
210(52) 190(48)
181 (68) 86(32)
29(22) 104(78)
Table2. Relationship between selection criteria and numberofchemicalswith evidence ofcarcinogenicity
nln^+inn aloesi Evidence of
carcinogenicity in
number sex/species
experiments
None
One
Two
Three
Four
Total for chemicals
with positive results
Total
190
55
79
31
45
210
Suspicion of
carcinogenicity (%)
86(45)
42(76)
70(89)
27 (87)
42(93)
181 (86)
Mainly human
exposure
considerations (%)
104(55)
13(24)
9(11)
4(13)
3 (7)
29(14)
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Table 3. IARC and AnnualReporton Carcinogens (ARC) classifications of chemicals selected for NCI/NTP
bioassay based on a suspicion of carcinogenicity
IARC category ARCclassification
Category 1 (5chemicals) Known carcinogens (4chemicals)
Asbestos Asbestos
Aspirin, phenacetin, caffeine mixture Aspirin, phenacetin, caffeine mixture
Benzene Benzene
Ethylene oxide 8-Methoxypsoralen + PUVA
8-Methoxypsoralen + PUVA Reasonablyanticipated to be
Category2A(10chemicals) carcinogens(51 chemicals)
5-Azacytidine 2-Aminoanthraquinone
1,3-Butadiene 1-Amino-2-methylanthraquinone
C.l. Direct Black38 o-Anisidine
C.l. Direct Blue 6 Bromodichloromethane
C.l. Direct Brown 95 1,3-Butadiene
1,2-Dibromoethane (EDB) Chlorendic acid
Procarbazine*HCI Chlorinated paraffins (C12, 60% chlorine)
1,2-Propylene oxide 3-Chloro-2-methylpropene
tris(Aziridinyl)phosphine sulfide (thio-TEPA) 4-Chloro-o-phenylenediamine
tris(2,3-Dibromopropyl)phosphate Cl. DirectBlack38
Category2B (42 chemicals) p-Cresidine
o-Anisidine Cupferron
Bromodichloromethane 2,4-Diaminoanisole sulfate
Chlordane 2,4-Diaminotoluene
Chlorendic acid 1,2-Dibromo-3-chloropropane
Chlorinated paraffins (C12, 60% chlorine) 1,4-Dichlorobenzene
4-Chloro-o-phenylene diamine Dichlorodiphenyltrichloroethane (DDT)
4-Chloro-o-toluidine 1,2-Dichloroethane
p-Cresidine 1,3-Dichloropropene
2,4-Diaminoanisole sulfate Diglycidol resorcinol ether
2,4-Diaminotoluene 3,3'-Dimethoxybenzidine dihydrochloride
1,2-Dibromo-3-chloropropane 3,3'-Dimethylbenzidine dihydrochloride
1,4-Dichlorobenzene Dimethyl vinyl chloride
Dichlorodiphenyltrichloroethane (DDT) Ethyl acrylate
p,p'-Dichlorodiphenyldichloroethylene (p,p'-DDE) Ethylene oxide
1,2-Dichloroethane Ethylene thiourea
1,3-Dichloropropene Hydrazobenzene
Dichlorvos (DDVP) Lindane
Diglycidol resorcinol ether Methylene chloride
3,3'-Dimethoxybenzidine dihydrochloride 4,4'-Methylene dianiline dihydrochloride
3,3'-Dimethylbenzidine dihydrochloride 4,4'-Methylenebis-(NN-dimethyl)benzenamime
Ethyl acrylate Michler's ketone
Ethylene thiourea Mirex
Heptachlor Nitrofen
Lasciocarpine Ochratoxin A
Methylene chloride 4,4'-Oxydianiline
4,4'-Methylene dianiline dihydrochloride Phenazopyridine*HCI
2-Methyl-1-nitroanthraquinone Phenoxybenzamine-HCI
Mirex Polybrominated biphenyl mixture
5-Nitroacenaphthene (Firemaster FF-1)
Nitrofen Procarbazine.HCI
Ochratoxin A 1,2-Propylene oxide
Phenazopyridine*HCI Reserpine
Phenoxybenzamine*HCI Sulfallate
Polybrominated biphenyl mixture (Firemaster FF-1) 2,3,7,8-Tetrachlorodibenzo-p-dioxin
Styrene Tetrachloroethylene
Sulfallate o-Toluidine*HCI
2,3,7,8-Tetrachlorodibenzo-p-dioxin Toxaphene
Tetrachloroethylene 2,4,6-Trichlorophenol
4,4'-Thiodianiline tris(Aziridinyl)phosphine sulfide (thio-TEPA)
o-Toluidine*HCI tris(2,3-Dibromopropyl)phosphate
Toxaphene
2,4,6-Trichlorophenol
course, exposure patterns and other neces-
sary conditions must also be considered
(28-30). Our current review of the 400
chemicals tested in the bioassay program
indicates that only 23% are positive in two
species, and thus, using international crite-
ria, these 92 chemicals may be considered
for further evaluation as being most likely
to pose carcinogenic risks to humans.
However, because the majority of chemi-
cals tested to date were selected as suspect
carcinogens, this must be considered to be
a high estimate. Only 6.8% ofthe chemi-
cals selected on the basis of exposure/pro-
duction volume may be considered as like-
ly to pose carcinogenic risks to humans.
Therefore, we predict that if all 75,000
chemicals in use were to be tested for car-
cinogenicity in the standard NTP bioassay,
significantly less than 50% would be car-
cinogenic in animals, and even a smaller
percentage (less than 5-10%) would need
further evaluation (Huffet al., submitted).
Relevance ofAnimal Studies to
Human Health
There are considerable molecular and cel-
lular similarities in carcinogenic processes
among mammals, including rodents and
humans (31-35). For those agents identi-
fied as carcinogenic to humans, experi-
ments in animals have shown remarkable
target organ concordance (36-40). Nearly
one-third of these agents confirmed as
causing cancer in humans were identified
first in experiments using laboratory ani-
mals (4,41-43). Nonetheless, Lijinsky (44)
reminds us that there are indeed differ-
ences in carcinogenic responses of various
species and strains to carcinogens, although
these differences have not yet been
explained (45).
Our evaluation and the knowledge that
all chemicals known to induce cancer in
humans that have been studied under ade-
quate experimental protocols also cause
cancer in laboratory animals (24,25,36,
37,39,46) leads to the persuasive specula-
tion that the obverse would often hold true:
chemicals shown to unequivocally induce
cancer in laboratory animals, especially in
multiple species, must be considered capa-
ble ofcausing cancer in humans. Obviously
further and detailed evaluations need to be
made. The International Agency for
Research on Cancer adopted this widely
accepted scientific view: "In the absence of
adequate data in humans, it is biologically
plausible and prudent to regard agents and
mixtures for which there is sufficient evi-
dence of carcinogenicity in experimental
animals as ifthey presented a carcinogenic
risk to humans" (25). This public health
statement has and should continue to be
endorsed and used by those responsible for
protecting human health.
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